{"id":474429,"date":"2020-03-17T12:12:01","date_gmt":"2020-03-17T12:12:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=474429"},"modified":"2020-03-17T12:12:01","modified_gmt":"2020-03-17T12:12:01","slug":"abdominal-aortic-aneurysm-analysis-market-size-epidemiology-leading-companies-and-competitive-analysis-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/abdominal-aortic-aneurysm-analysis-market-size-epidemiology-leading-companies-and-competitive-analysis-by-delveinsight_474429.html","title":{"rendered":"Abdominal Aortic Aneurysm Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis By DelveInsight"},"content":{"rendered":"
\"Abdominal<\/a><\/div>\n

DelveInsight has launched a new report on Abdominal Aortic Aneurysm Market Insights, Epidemiology and Market Forecast-2030<\/strong><\/p>\n

DelveInsight’s “Abdominal Aortic Aneurysm<\/strong> Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Abdominal Aortic Aneurysm<\/strong>, historical and forecasted epidemiology as well as the Abdominal Aortic Aneurysm<\/strong> market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/em><\/p>\n

Abdominal Aortic Aneurysm (AAA) is a localized enlargement of the abdominal aorta such that the diameter is greater than 3 cm or more than 50% larger than usual. It occurs when atherosclerosis or plaque buildup causes the walls of the abdominal aorta to become weak and bulge outward like a balloon. It develops slowly over time and has few noticeable symptoms. The larger an aneurysm grows, the more likely it will burst or rupture, causing intense abdominal or back pain, dizziness, nausea or shortness of breath. Most people with an abdominal aortic aneurysm do not have any symptoms. Often, the aneurysm grow slowly and go unnoticed. Many never reach the point of bursting; others enlarge quickly. When an abdominal aneurysm expands, the patient may notice a throbbing in the middle or lower part of the stomach, lower back pain, or tenderness in the chest. Most abdominal aneurysms are identified during routine medical exams.<\/div>\n
 <\/div>\n
 <\/div>\n
 <\/div>\n
\"\"<\/strong><\/div>\n
 <\/div>\n
 <\/div>\n
Request for :- <\/strong>Abdominal Aortic Aneurysm free sample page<\/em><\/a><\/div>\n
 <\/div>\n
 <\/div>\n
Abdominal Aortic Aneurysm Epidemiology<\/strong><\/div>\n
The Abdominal Aortic Aneurysm epidemiology division provide insights about historical and current Abdominal Aortic Aneurysm <\/span>patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.<\/span><\/div>\n
 <\/div>\n
Report Key Facts are given below :- <\/strong><\/div>\n
 <\/div>\n
1.<\/strong> As per the study conducted by Palma M. Shaw et al. (2019), the prevalence of abdominal aortic aneurysms increases after age 60, and it peaks in the seventh and eighth decades of life.<\/div>\n
 <\/div>\n
2<\/strong>. As per the study conducted by Anna Hohnecket al. (2019), in 40 of 566 patients (7.1%), AAAs were detectable. 14 patients (2.5%) had a first diagnosis of AAA, none of which was large (>55 mm), the remaining 26 patients were either already diagnosed (14 patients, 2.5%) or previously treated (12 patients, 2.1%).<\/div>\n
 <\/div>\n
3<\/strong>. Data derived from Lifeline AAA screening and National Health and Nutrition Examination Survey (NHANES, 2003-2006<\/span>) database <\/span>reveals a prevalence of 1.4% or 1.1 million AAAs in those studied aged <\/span>50–84<\/span><\/div>\n
 <\/div>\n
 <\/div>\n
Key Benefits of Report:-<\/strong><\/div>\n
 <\/div>\n
1. Abdominal Aortic Aneurysm<\/strong> market report covers a descriptive overview and comprehensive insight of the Abdominal Aortic Aneurysm<\/strong> epidemiology Abdominal Aortic Aneurysm<\/strong> market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/div>\n
\n

2. Abdominal Aortic Aneurysm<\/strong> market report provides insights on the current and emerging therapies. <\/p>\n

3. Abdominal Aortic Aneurysm<\/strong> market report offers a global historical and forecasted market covering drug outreach in 7 MM.<\/p>\n

4. Abdominal Aortic Aneurysm<\/strong> market report provides an edge that will help in developing business strategies by understanding trends shaping and driving the Abdominal Aortic Aneurysm<\/strong> market.<\/p>\n<\/div>\n

 <\/div>\n

“According to the  National Center for Chronic Disease Prevention and Health Promotion, Abdominal aortic aneurysms are more common in men”<\/strong><\/em><\/p>\n

 <\/div>\n
Some of the key companies working on Abdominal Aortic Aneurysm <\/strong>that are given below:- <\/span><\/strong><\/div>\n
 <\/div>\n
1. Merck Serono Pharma Co. <\/div>\n
2. AstraZeneca Pharma Co. <\/div>\n
 <\/div>\n
\n

Name of covered Drugs are given below:- <\/strong><\/p>\n

1.<\/strong> Metformin Glucophage<\/p>\n

2<\/strong>. Ticagrelor<\/span><\/p>\n<\/div>\n

 <\/div>\n
Table of Contents<\/a><\/div>\n
 <\/div>\n
\n

1. Key Insights<\/span><\/p>\n

2. Executive Summary of Abdominal Aortic Aneurysm<\/span><\/p>\n

3. Competitive Intelligence Analysis for Abdominal Aortic Aneurysm<\/span><\/p>\n

4. Abdominal Aortic Aneurysm : Market Overview at a Glance<\/span><\/p>\n

5. Abdominal Aortic Aneurysm : Disease Background and Overview<\/span><\/p>\n

6. Patient Journey<\/p>\n

7. Abdominal Aortic Aneurysm Epidemiology and Patient Population<\/span><\/p>\n<\/div>\n

\n

8. Treatment Algorithm, Current Treatment, and Medical Practices<\/span><\/p>\n

9. Unmet Needs<\/p>\n

10. Key Endpoints of Abdominal Aortic Aneurysm Treatment<\/span><\/p>\n

11. Marketed Products<\/span><\/p>\n<\/div>\n

\n

12. Emerging Therapies<\/span><\/p>\n

13. Abdominal Aortic Aneurysm : Seven Major Market Analysis<\/p>\n

14. Attribute analysis<\/p>\n

15. 7MM: Market Outlook<\/span><\/p>\n<\/div>\n

\n

16. Access and Reimbursement Overview of Abdominal Aortic Aneurysm<\/span><\/p>\n

17. KOL Views<\/span><\/p>\n

18. Market Drivers<\/span><\/p>\n

19. Market Barriers<\/span><\/p>\n

20. Appendix<\/span><\/p>\n

21. DelveInsight Capabilities<\/span><\/p>\n

22. Disclaimer<\/span><\/p>\n

23. About DelveInsight<\/span><\/p>\n

Why should you buy this Abdominal Aortic Aneurysm market report?<\/strong><\/p>\n